RecruitingNCT07295483

Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)

Studying Acute graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Instituto de Investigación Biomédica de Salamanca
Principal Investigator
Manuel Angel Gomez Marcos, MD, PhD
Centro Asistencial Universitario de Salamanca (CAUSA)
Intervention
BioICOPER Long COVID Cohort(other)
Enrollment
400 target
Eligibility
18 years · All sexes
Timeline
2026 – 2029

Study locations (1)

Collaborators

Carlos III Health Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07295483 on ClinicalTrials.gov

Other trials for Acute graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Acute graft versus host disease →

← Back to all trials